APOB and coronary artery disorder: Above all, INTERHEART provides answer for the quest for a single reliable biomarker, the Apo B/ApoA 1 ratio that can predict the future CHD risk relieving physicians from the complexities of monitoring various fractions of blood fats and other conventional and unconventional risk factors.